DE69108568D1 - Diagnose für bösartige hyperthermia im schwein. - Google Patents

Diagnose für bösartige hyperthermia im schwein.

Info

Publication number
DE69108568D1
DE69108568D1 DE69108568T DE69108568T DE69108568D1 DE 69108568 D1 DE69108568 D1 DE 69108568D1 DE 69108568 T DE69108568 T DE 69108568T DE 69108568 T DE69108568 T DE 69108568T DE 69108568 D1 DE69108568 D1 DE 69108568D1
Authority
DE
Germany
Prior art keywords
pct
vicious
hyperthermia
pig
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69108568T
Other languages
English (en)
Other versions
DE69108568T3 (de
DE69108568T2 (de
Inventor
David Maclennan
Peter O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THE GOVERNING COUNCIL OF THE UNIVERSITY OF TOR, CA
University of Guelph
Original Assignee
Innovations Foundation of University of Toronto
University of Guelph
University of Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27265419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69108568(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909027869A external-priority patent/GB9027869D0/en
Priority claimed from GB919110865A external-priority patent/GB9110865D0/en
Priority claimed from GB919119250A external-priority patent/GB9119250D0/en
Application filed by Innovations Foundation of University of Toronto, University of Guelph, University of Toronto filed Critical Innovations Foundation of University of Toronto
Publication of DE69108568D1 publication Critical patent/DE69108568D1/de
Application granted granted Critical
Publication of DE69108568T2 publication Critical patent/DE69108568T2/de
Publication of DE69108568T3 publication Critical patent/DE69108568T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Finger-Pressure Massage (AREA)
  • Electrotherapy Devices (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69108568T 1990-12-21 1991-12-20 Diagnose für bösartige hyperthermia im schwein. Expired - Lifetime DE69108568T3 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9027869 1990-12-21
GB909027869A GB9027869D0 (en) 1990-12-21 1990-12-21 Diagnosis for porcine malignant hyperthermia
GB9110865 1991-05-20
GB919110865A GB9110865D0 (en) 1991-05-20 1991-05-20 Diagnosis for porcine malignant hyperthermia
GB919119250A GB9119250D0 (en) 1991-09-09 1991-09-09 Diagnosis of porcine malignant hyperthermia
GB9119250 1991-09-09
PCT/CA1991/000457 WO1992011387A1 (en) 1990-12-21 1991-12-20 Diagnosis for porcine malignant hyperthermia

Publications (3)

Publication Number Publication Date
DE69108568D1 true DE69108568D1 (de) 1995-05-04
DE69108568T2 DE69108568T2 (de) 1995-12-14
DE69108568T3 DE69108568T3 (de) 2004-03-04

Family

ID=27265419

Family Applications (2)

Application Number Title Priority Date Filing Date
DE92901384T Pending DE563144T1 (de) 1990-12-21 1991-12-20 Diagnose für bösartige hyperthermia im schwein.
DE69108568T Expired - Lifetime DE69108568T3 (de) 1990-12-21 1991-12-20 Diagnose für bösartige hyperthermia im schwein.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE92901384T Pending DE563144T1 (de) 1990-12-21 1991-12-20 Diagnose für bösartige hyperthermia im schwein.

Country Status (12)

Country Link
US (1) US5358649A (de)
EP (1) EP0563144B2 (de)
AT (1) ATE120488T1 (de)
AU (1) AU665178B2 (de)
CA (2) CA2064091C (de)
DE (2) DE563144T1 (de)
DK (1) DK0563144T4 (de)
ES (1) ES2072749T5 (de)
IE (1) IE67816B1 (de)
NZ (1) NZ241112A (de)
WO (1) WO1992011387A1 (de)
ZA (1) ZA9110087B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668006A (en) * 1992-07-17 1997-09-16 American Cyanamid Company Somatostatin receptors
GB9503808D0 (en) * 1995-02-24 1995-04-12 Univ Nottingham Detection assay
AU4566997A (en) * 1996-10-07 1998-05-05 Meat And Livestock Commission Assay for duroc muscle fibre type
GB2333154B (en) * 1996-10-07 2001-05-09 Meat And Livestock Commission Assay for duroc muscle fibre tyre
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
ES2203958T3 (es) * 1997-05-20 2004-04-16 Biotechnology Research And Development Corporation Metodos y composiciones para la identificacion de cerdos geneticamente resistentes a enfermedades relacionadas con e. coli f18.
US6306591B1 (en) 1997-06-18 2001-10-23 Utah State University Screening for the molecular defect causing spider lamb syndrome in sheep
EP1026244A1 (de) * 1999-02-03 2000-08-09 Europäisches Laboratorium Für Molekularbiologie (Embl) Proteine, die den G2/M Übergang auslösen und die mit CDC2 und Cyclin B interagieren können
NO314277B1 (no) * 1999-06-08 2003-02-24 Unifob Stiftelsen Universitets Deteksjon av ryanodin-reseptor-antistoff
EP1781784A2 (de) 2004-08-02 2007-05-09 BASF Plant Science GmbH Verfahren zur isolierung von transkriptionsterminationssequenzen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341094C (en) * 1989-09-25 2000-09-05 Ronald G. Worton Diagnosis for malignant hyperthermia

Also Published As

Publication number Publication date
ES2072749T5 (es) 2003-11-16
CA2064091C (en) 1993-03-16
CA2064091A1 (en) 1992-06-22
ATE120488T1 (de) 1995-04-15
IE67816B1 (en) 1996-05-01
DK0563144T4 (da) 2003-03-31
NZ241112A (en) 1993-09-27
DE69108568T3 (de) 2004-03-04
DE563144T1 (de) 1994-02-03
WO1992011387A1 (en) 1992-07-09
CA2079702A1 (en) 1992-06-22
ZA9110087B (en) 1992-10-28
AU9103891A (en) 1992-07-22
DE69108568T2 (de) 1995-12-14
EP0563144A1 (de) 1993-10-06
US5358649A (en) 1994-10-25
EP0563144B1 (de) 1995-03-29
DK0563144T3 (da) 1995-08-28
ES2072749T3 (es) 1995-07-16
IE914495A1 (en) 1992-07-01
EP0563144B2 (de) 2003-02-19
AU665178B2 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
DE69130506T2 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
DE69108568D1 (de) Diagnose für bösartige hyperthermia im schwein.
ATE187732T1 (de) Hydrophile metallkomplexe
GR3022052T3 (en) Dna sequences which code for virulence characteristics of --(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by --(s. suis) in mammals, including man
DE69232483D1 (de) Mycobacteriumprotein und dessen verwendung
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
ATE228164T1 (de) Chemotaktische faktoren
NO993653D0 (no) Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer
ATE348158T1 (de) Neuartiges collectin
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
NZ334241A (en) Diagnosis of onset of bovine leukemia virus (BLV) and the resistance thereto
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
BR9609114A (pt) Composição inseticida de terra diatomácea
ATE412751T1 (de) Menschliche tak1 und für diese kodierende dna

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TOR, CA

Owner name: UNIVERSITY OF GUELPH, GUELPH, ONTARIO, CA